Quintrio
Home

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Sensus Healthcare, Inc

SRTS

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Last trade $2.24
Day change -$0.105 (-4.49%)
Day range $2.16 – $2.37
Volume 197,087
Market cap $39M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$38.52M
Price / earnings
—
Price / book
1.04×
Price / sales
2.2×
EV / sales
1.33×
EV / EBITDA
-1.81×

Profitability

Earnings per share
-$0.94
Return on assets
-37.53%
Return on equity
-42.01%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
8.71×
Quick ratio
4.44×
Cash ratio
3.51×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$6.97M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for SRTS, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$2.29M$3.39M$4.94M$6.88M$7.32M$8.34M$13.07M$8.84M
Cost of revenue$1.52M$2.4M$3.04M$4.17M$4.41M$3.99M$5.96M$3.6M
Gross profit$769K$991K$1.9M$2.71M$2.9M$4.35M$7.11M$5.24M
Selling, general and administrative$2.84M$3.76M$3.16M$3.46M$3.38M$4.39M$3.82M$2.88M
Research and development$1.11M$1.59M$1.88M$1.82M$1.47M$2.61M$1.56M$863K
Total operating expenses$3.95M$5.35M$5.05M$5.28M$4.85M$7M$5.38M$3.75M
Operating income-$3.18M-$4.36M-$3.15M-$2.57M-$1.94M-$2.65M$1.73M$1.5M
Interest expense$0$0$155K$160K$0$0$230K$279K
Income before taxes-$3.06M-$4.23M-$2.99M-$2.41M-$1.76M-$2.46M$1.96M$1.77M
Income taxes$5.69M-$1.61M$174K-$1.47M-$723K$110K$410K$559K
Net income-$8.75M-$2.63M-$3.17M-$943K-$1.04M-$2.57M$1.55M$1.22M
Net income attributable to common shareholders-$8.75M-$2.63M-$3.17M-$943K-$1.04M-$2.57M$1.55M$1.22M
EBITDA-$3.09M-$4.26M-$3.05M-$2.47M-$1.84M-$2.56M$1.81M$1.55M
Basic earnings per share-$0.53-$0.16-$0.19-$0.06-$0.06-$0.16$0.09$0.07
Diluted earnings per share-$0.53-$0.16-$0.19-$0.06-$0.06-$0.16$0.09$0.07

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.